Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DR26FHKR5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,317
Award facts
- Contract value 100% obligated
- $69,316.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,316.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The award, issued on November 20, 2025, with an ultimate completion date of December 12, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will take place in Park Ridge, Illinois. DMS Pharmaceutical Group holds no identified subcontractors for this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs of Department of Defense healthcare facilities worldwide. The underlying IDC, designated contract SPE2DR and awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As a critical pharmaceutical supplier within the federal military medical supply chain, DMS Pharmaceutical Group supplies an extensive portfolio of branded and generic prescription drugs, biologics, vaccines, and specialty pharmaceuticals to support DOD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FHKR5?
SPE2DR26FHKR5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FHKR5 worth?
The government has obligated $69,317 on SPE2DR26FHKR5.
Is contract SPE2DR26FHKR5 an order under another contract?
Yes. SPE2DR26FHKR5 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKR5 competed?
The extent of competition for SPE2DR26FHKR5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award